A duplex PCR for rapid and simultaneous detection of Brucella spp. in human blood samples.  by Mirnejad, Reza et al.
453Asian Pacific Journal of Tropical Medicine (2013)453-456
Document heading          doi:  
A duplex PCR for the rapid and simultaneous detection of
Brucella spp. in human blood samples
Reza Mirnejad1, Mozafar mohamadi1, Vahbeh Piranfar1*, Seied Mojtaba Mortazavi2, Reza Kachuei1
1Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
2Health Station, Kerman University of Medical Sciences, Kerman, Iran
 Contents lists available at ScienceDirect
Asian Pacific Journal of Tropical Medicine
journal homepage:www.elsevier.com/locate/apjtm
ARTICLE INFO                           ABSTRACT
Article history:
Received 10 March 2013
Received in revised form 15 April 2013
Accepted 15 May 2013
Available online 20 June 2013
Keywords:
Brucella abortus
Brucella melitensis
Brucella ovis
Duplex PCR
  *Corresponding author: Vahbeh Piranfar, Molecular Biology Research Center, 
Baqiyatallah University of Medical Sciences, Tehran, Iran.
     Tel: + 98 (21) 82482558
     Fax: + 98 (21) 88039883
     E-mail: rmirnejadreza@yahoo.com
    Foundation project: This study is graduate thesis (MSc) that was financially supported 
by Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, with 
grant number BMSU/MBRC- 90-001.
1. Introduction
  Infection with Brucella species (Brucellosis) is worldwide 
in distribution and become recognized as a zoonosis[1]. 
Brucella is small, aerobic, nonfermenting, nonmotile, 
noncapsules, nonspore, and facultative intracellular, Gram-
negative coccobacillus[2]. The genus Brucella consists of 
10 species, of which Brucella abortus (B. abortus), Brucella 
melitensis (B. melitensis), Brucella ovis (B. ovis), Brucella 
canis (B. canis) and Brucella suis (B. suis) are pathogenic 
for humans. Brucella microti (B. microti), Brucella 
inopinata (B. inopinata), Brucella ceti (B. ceti) and Brucella 
pinnipediali (B. pinnipedialis) are isolated from animals 
but can occasionally cause disease in man[3,4]. Among these 
species, the main species in humans are B. abortus and
B. melitensis.They cause brucellosis, also known as 
undulant fever[1,2]. In most developed countries, this 
disease well controlled but in South and Central America, 
Africa, Asia and the Middle East the clinical disease is 
still common[5,6]. In Iran, two species of B. melitensis and 
B. abortus are more common[6]. These species in humans 
and animals cause forms of the disease which can only be 
diagnosed through laboratory methods[1,7]. Since the clinical 
feature of the disease is nonspecific; the most reliable 
way to diagnose disease is isolation of the bacterium 
from blood or infected tissues by culture[8]. Factors such 
as the sample type, sampling time (stage of the disease) 
and sample preparation equipment for manipulation and 
isolation technique affected the success rates of culture 
methods[8,9]. In addition, serological tests that were replaced 
to culture methods, have little sensitivity, especially in 
the early stages of the disease that production rate of 
the antibody is low[7,9-12]. Thus, in different parts of the 
world, molecular diagnostic techniques with the power to 
discriminate different species of Brucella are currently used 
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for diagnosis[13-15]. 
  Duplex PCR assay is a variant of PCR in which two or more 
loci are simultaneously amplified in the same reaction. 
Therefore, nowadays, it is used for rapid simultaneous 
detection of different pathogens, as well as for identification 
of different genetic disorders and for evaluation the quality 
and quantity of the samples[16-18]. This study was designed 
for rapid and simultaneous detection of Brucella species in 
human blood samples by duplex PCR assay.
2. Materials and methods
2.1. Clinical specimens
  A total of 52 blood samples were collected from suspicious 
patients with brucellosis with different ages in Kerman 
provinces. Three mL blood that mixed with EDTA for 
extracting DNA was taken from suspected cases. Samples 
were transferred to laboratory and were kept for 3 weeks at 
37 曟 in incubator.
2.2. Isolation of DNA from clinical blood samples
  A modification of the method described by Queipo-
Ortuño et al[19] was used. Briefly, 0.5 mL of blood with
1 mL of erythrocyte lysis solution [320 mM saccharose, 5 mM 
MgCl2, 1% Triton 伊-100, 10 mM Tris HCl (pH 7.5)], mixed, 
and centrifuged at 15 000 × g for 2 min. The supernatant was 
discarded, and above steps was repeated for four times until 
the pellet lost all reddish coloring. Four hundred microliters 
of nucleic lysis buffer  [10 mM Tris-HCl,1% SDS,10 mM 
EDTA, 10 mM sodium acetate (pH 8)] containing proteinase 
K (10 mg/mL) was mixed  and incubated for 30 min at 55 曟 
in shaker incubator. Followed, 100 mL of ammonium acetate 
(7.5 M) was added and centrifugation at 15 000 × g for 10 min. 
To supernatant, two volumes of absolute ethanol were added, 
and after centrifuging at 15 000 × g for 10 min; the pellets 
were dissolved in 25 毺L of TE buffer (pH 8.0) and stored at
4 曟 for PCR or at -20 曟 for long-term storage.
2.3. Primers 
  After studying the genes and primers which were used 
so far for detection of Brucella species and based on 
the sensitivity and specificity of the primers and their 
analysis with BLAST molecular software, suitable primers 
were selected for simultaneous detection of the species of
B. abortus, B. melitensis and B. ovis as follow:
IS711: 5’-TGCCGATCACTTAAGGGCCTTCAT-3’
B1-F: 5’-AAATCGCGTCCTTGCTGGTCTGA-3’
B2-F: 5’-GACGAACGGAATTTTTCCAATCCC-3’
 
2.4. PCR amplification 
  Each PCR reaction mixture contained 15 毺L Master mix 1
伊 (Ampliqon Co, Denmark) that contained 1 × PCR buffer, 1.5 
mM MgCl2, 1 毺L template DNA ( 0.5 毺g), 0.15 mM dNTP, 
1.25 U Taq DNA polymerase, 20 pmol of each forward and 
reverse primers and sterile distilled water up to 50 毺L. 
  PCR were performed in a GenAmp PCR system (Eppendorf, 
USA)) according to the following program: predenaturation 
for 5 min at 94 ℃ followed by 35 cycles each containing 
denaturation at 94 ℃ for 45 s, annealing at 66 ℃ for 45 s and 
Extension at 72 ℃ for 60 s, followed by final extension at
72 ℃ for 5 min.
  Then, The PCR products were analyzed using the 
electrophoresis technique on 1.5% agarose gel for 1 h at 85 V
and 25 mA, stained by SYBERgreen and visualized under 
UV transilluminator. Finally, amplification products were 
further evaluated by sequencing and restriction digestion 
procedures. 
  Extracted genomes of vaccine strains of B. abortus B-19 
and B. melitensis Rev-1 as positive control and suspension 
containing all of the reagents except template as negative 
control were used. All PCRs were carried out in duplicate.
2.5. Staistical analysis
  The results were analyzed as positive or negative PCR 
amplification reaction for each bacterium separately, as 
well as for two or three bacteria simultaneously. Descriptive 
analyses were performed and results are presented as 
number (%). 
3. Results
  Of the 52 suspicious patients tested had a mean age of 
31.9 years (SD=9.7) and a mean duration of symptoms before 
diagnosis of 20 d (SD=5). There was no significant difference 
between sex and infection by brucellosis. Most of patients 
were in direct contact with livestock.
  In this study, twenty five cases (48%) were positive by PCR 
method (Figure 1). The isolation rate for B. melitensis was 
25% (13 cases), B. abortus 23% (12 cases) and B. ovis 0% (0 
cases). 
  For confirmation of the PCR results, the amplified DNA 
products were subjected to DNA sequencing as well as 
restriction endonuclase digestion. The amplified bands 
pertaining to B. abortus and B. melitensis were cut with TaqI 
(92 bp and 402 bp fragments) and RasI (105 bp and 628 bp 
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fragments), respectively (Figure 2).
1            2             3           4
733 bp
494 bp
Figure 1. Agarose gel electrophoresis of PCR amplified products 
generated from DNA samples. 
Lane 1 shows DNA size marker (100 bp DNA ladder, SM#333).
Lanes 2 and 3 show 733 bp B. melitensis and 494 bp B. abortus 
amplification product. Lane 4 is negative control.
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Figure 2. Restriction fragment length polymorphism (RFLP) patterns 
of PCR products from B. abortus and B. melitensis after digestion with 
Taq1 and Rsa 1 restriction enzyme. 
Lanes 1 and 2: PCR-RFLP pattern of B. abortus after digestion with 
Rsa1; lane 3: 494 bp-long PCR product from B. abortus as the positive 
control; Lane 4 is DNA size marker (100 bp DNA ladder, SM#333); 
Lanes 5 and 6: 733 bp-long PCR product from B. melitensis as the 
positive control; Lane 7: PCR-RFLP pattern of B. melitensis after 
digestion with Taq1.
4. Discussion
  Although brucellosis has been largely eradicated from 
some parts of the world, but it has not been eradicated from 
many countries (eg. Iran)[1,5,6]. This disease with nonspecific 
clinical picture is caused by Brucella species especially to 
B. melitensis and B. abortus[2,3]. Isolation of bacteria from 
clinical samples (especially human blood samples) with 
serology or culture methods to isolate microorganisms is 
very time consuming and costly; on the other hand, rapid 
diagnosis and differentiation of various bacterial species, 
especially slow-growing ones, is possible with molecular 
methods[7,9,13,14]. Therefore, this study was designed for rapid 
and simultaneous detection of Brucella species in human 
blood samples by duplex PCR assay.
  Since duplex PCR is a technique that is able to detect 
several microorganisms simultaneously in a single 
amplification reaction within less than 8 h without 
interference with other microorganisms present in 
samples[14,18]. This method is done by adding several pairs 
of primers under standard conditions. Studies have shown 
that in PCR, especially the duplex PCR, it is important 
that various concentrations of reaction components 
(concentrations of MgCl2, dNTP and Taq polymerase) 
be proportionate to obtain the highest efficiency. The 
concentration should be optimized, since primers may 
act differently. Also, finding denaturation temperature, 
denaturation duration, and the annealing temperature are 
important issues which are costly and time consuming and 
require expert personnel[13,15]. In this study, unlike studies 
conducted by Kumar and López-Goñi for simultaneous 
detection and differentiation of species, particularly
B. abortus, B. melitensis from several pairs of primers (for 
each microorganism = one primer pair)[16,20], only 3 primers 
were used for isolation and differentiation of B. abortus,
B. melitensis and B. ovis in human blood samples. Using 
these three primers and through duplex PCR, which is rather 
similar to conventional PCR, we were able to rapid identify 
three species of bacteria in a short time (less than 8 h) which 
seems to reduce the costs and the time of diagnosis. 
  In this study, like other studies conducted in Iran the 
isolated rate of B. melitensis was higher, but cases of isolated 
B. abortus were considerable[21,22].
  The results of the present study, just like those of Queipo-
Ortuño et al proved that peripheral-blood-based PCR 
assay is a rapid method, easy to perform, and it is no risks 
to laboratory personnel  and suitable method for Brucella 
species detection from human blood samples[19].
  The result of this study is unlike to study of Kazemi et al
that the isolated rate of Brucella 70%, reported[22]. The 
minute difference in the results of these two studies may be 
due to the number of subjects, geographical regions under 
study and the target specificities of the primers used for the 
amplification reactions.
  Despite the fact that more studies are needed in order 
to elucidate the efficacy and effectiveness of using three 
primers in duplex PCR assay in clinical samples, the results 
of this survey clearly indicated that this assay system was 
simple, fast, and highly specific for detection of Brucella 
species (especially B. abortus and B. melitensis) in human 
blood samples. Since simultaneous, rapid and accurate 
differentiation of Brucella species is very important in 
patients, the duplex PCR developed in this survey could be 
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a suitable alternative to other Brucella species identification 
methods such as bacterial culture and serology in human 
blood samples.
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